Jennifer Lachey - Jun 11, 2021 Form 4 Insider Report for Keros Therapeutics, Inc. (KROS)

Signature
/s/ Keith Regnante, Attorney-in-Fact
Stock symbol
KROS
Transactions as of
Jun 11, 2021
Transactions value $
-$134,292
Form type
4
Date filed
6/15/2021, 05:02 PM
Previous filing
May 13, 2021
Next filing
Jun 25, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KROS Common Stock Options Exercise $795 +2.65K +3.4% $0.30* 80.6K Jun 11, 2021 Direct
transaction KROS Common Stock Sale -$77.2K -1.53K -1.9% $50.37 79K Jun 11, 2021 Direct F1, F2
transaction KROS Common Stock Sale -$46.5K -898 -1.14% $51.73 78.1K Jun 11, 2021 Direct F1, F3
transaction KROS Common Stock Sale -$11.4K -219 -0.28% $52.13 77.9K Jun 11, 2021 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KROS Employee Stock Option (right to buy) Options Exercise $0 -2.65K -2% $0.00 130K Jun 11, 2021 Common Stock 2.65K $0.30 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.96 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4).
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.065 to $52.05 inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.12 to $52.53 inclusive.
F5 Immediately exercisable.